Dr Philip Cruz
Vaccines Medical Director
Dr Philip Cruz is the current medical director of GlaxoSmithKline Vaccines for the United Kingdom and Ireland. He graduated from the University of the Philippines - Manila College of Medicine with a specialization in the field of Paediatrics in 2001. After specialization Dr Cruz went into clinical research namely vaccine clinical trials and also acted as a consultant for pharmaceutical and biotechnology companies. Subsequently, he has co-authored publications in peer-reviewed journals and presented in regional and international conferences and symposia.
In 2010, Dr Cruz took on a position with GlaxoSmithKline Biologicals in Belgium as a senior manager in the Clinical and Research Division of Medical Affairs – Paediatric vaccines. His scope was within the vaccine medical and scientific affairs of the Emerging Markets geographically from Africa, Middle East, Russia, South Asia to China. In this role, he has had the opportunity to interact with Ministries of Health, technical advisory groups and local experts to ascertain the public health burden of vaccine preventable paediatric diseases. In 2013, he then took a role as the Area Medical Leader for Asia Pacific and North Asia where he was responsible for providing a scientific case (including facilitating any necessary health economics, epidemiological and clinical data) to expedite the introduction in government immunization programmes of new vaccines which may over the years potentially save the lives of millions of children across the Asian region. Dr Cruz then was subsequently assigned to his current role since 2015 to further support the clinical and medical affairs initiatives of GlaxoSmithKline in the United Kingdom and Ireland.
Life course vaccination: the role of the pharmacist
The NHS Long Term Plan’s ambition to save lives and improve patient outcomes through investing in innovation to prevent, detect and treat disease was launched in 2018. Vaccination is of growing importance and pharmacists can help shape how patients access vaccines. Vaccination programmes that protect individuals throughout all stages and circumstances of their lives are needed. Moreover the changing demographics of our nation’s population require new vaccination strategies. Get to know the different stages of how the immune system adapts to aging and the basic principles around this concept.
This interactive session will look at the vaccinology of key vaccines focussing on the science and technology behind vaccine manufacture, the cold chain and the crucial role that pharmacists can play.